arrow
G

George N. Ioannou

veterans affairs puget sound health care system and university of washington
H指数:69
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rates and Factors Associated With Hepatocellular Carcinoma Diagnosis, Stage, Treatment, and Survival

肝细胞癌诊断、分期、治疗及生存相关的速率和因素

2026-01-010
OAAI
Illness Experiences of Veterans Reporting Long-Term Symptoms or Health Challenges from COVID-19: Results from the VA COVID-19 Observational Research Collaboratory

退役军人报告长期症状或健康挑战的COVID-19疾病经历:来自VA COVID-19观察性研究协作体的结果

2025-12-010
PRE
Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening

肝病病因学的变化支持降低甲胎蛋白阈值用于肝细胞癌筛查

2025-11-140
PRE
Practice Changing RCT Design and Rationale: Abbreviated MRI plus AFP vs ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)

实践变革RCT设计与原理:缩写MRI联合AFP与超声联合AFP用于肝硬化肝癌筛查(PREMIUM研究)

2025-11-060
OAAI
Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 Infection

SARS-CoV-2感染后退伍军人心理健康急诊医疗服务利用

2025-06-050
PRE
Target Trial Emulation of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus No Infection and Risk of Post-Coronavirus Disease 2019 Conditions in the Omicron Variant Versus Prior Eras
2025-04-010
PRE
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study

呼吸道合胞病毒疫苗在美国退伍军人中的有效性:2023年9月至2024年3月——一项目标试验模拟研究

2025-01-010
PRE
Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma
2024-12-011
PRE